BALVERSA

Identification of Balversa

No description

Google image searchProduct monograph

Active ingredient

erdafitinib, 3 MG

DIN: 02493217

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: JANSSEN INC

Date: 09-DEC-2019

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EN — Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors (ATC, ATC/DDD)
• L01EN01 — ERDAFITINIB (ATC/DDD)

Reference brand drug: Balversa

External Links for Balversa

Search on Google

• Balversa side effects
• Balversa dosage
• erdafitinib side effects
• erdafitinib dosage

Janssen Inc

Go to Janssen website to see drug product details. Sometimes you can find balversa photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.